12 reports

One unit consists of one disposable insulin pump.

  • Diabetes Care
  • Insulin
  • Insulin Delivery
  • Stroke
  • Roche Group

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Insulin
  • Stroke
  • Therapy
  • United States
  • Product Initiative

One unit refers to one disposable insulin pen.

  • Clinical Trial
  • Healthcare
  • Insulin
  • Stroke
  • Pfizer Inc.

One external remote patient monitoring device consists of one external module or transmitter.

  • Cardiovascular Disease
  • Insulin
  • Stroke
  • United States
  • Pfizer Inc.

One unit refers to one disposable insulin pen.

  • Clinical Trial
  • Healthcare
  • Insulin
  • Stroke
  • Sanofi S.A.

PHIN-## (PGC GLP-## (GLUCAGON-LIKE PEPTIDE-##)) DELIVERS FULLY ACTIVE NATIVE HUMAN GLP-##.

  • Chronic Disease
  • Insulin
  • Stroke
  • United States
  • Company

FURTHERMORE, CGEN-## SHOWED EFFICACY SIMILAR TO THAT OBSERVED THROUGH TNF-ALPHA BLOCKADE WITH TNFR-FC, ENBREL, A WIDELY USED BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD).

  • Insulin
  • Stroke
  • United States
  • Company
  • Product Initiative
  • STROKE - PIPELINE BY SAVARA INC, H1 2018
  • STROKE - PIPELINE BY SHIN POONG PHARMCO LTD, H1 2018

The company provides cardiovascular, psychoneurotic, anti-cancer, antihistamine, antirheumatic and benign prostatic hyperplasia drugs.

  • Chronic Disease
  • Insulin
  • Stroke
  • Company
  • Product Initiative
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H1 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Insulin
  • Stroke
  • United States
  • Company Operations
  • AB Science SA
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H2 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Insulin
  • Stroke
  • Therapy
  • Product Initiative
  • AB Science SA

BUT IT IS ONE OF THE MOST IMPORTANT POINTS!

  • Insulin
  • Stroke
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.